177 related articles for article (PubMed ID: 34425860)
1. iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes.
Ensenyat-Mendez M; Íñiguez-Muñoz S; Sesé B; Marzese DM
BioData Min; 2021 Aug; 14(1):42. PubMed ID: 34425860
[TBL] [Abstract][Full Text] [Related]
2. Identification of five important genes to predict glioblastoma subtypes.
Tang Y; Qazi MA; Brown KR; Mikolajewicz N; Moffat J; Singh SK; McNicholas PD
Neurooncol Adv; 2021; 3(1):vdab144. PubMed ID: 34765972
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
[TBL] [Abstract][Full Text] [Related]
4. Correction to: iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes.
Ensenyat-Mendez M; Íñiguez-Muñoz S; Sesé B; Marzese DM
BioData Min; 2021 Nov; 14(1):47. PubMed ID: 34789311
[No Abstract] [Full Text] [Related]
5. Gene clusters based on OLIG2 and CD276 could distinguish molecular profiling in glioblastoma.
Fu M; Zhang J; Li W; He S; Zhang J; Tennant D; Hua W; Mao Y
J Transl Med; 2021 Sep; 19(1):404. PubMed ID: 34565408
[TBL] [Abstract][Full Text] [Related]
6. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
7. Master regulators, regulatory networks, and pathways of glioblastoma subtypes.
Bozdag S; Li A; Baysan M; Fine HA
Cancer Inform; 2014; 13(Suppl 3):33-44. PubMed ID: 25368508
[TBL] [Abstract][Full Text] [Related]
8. Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.
Zhang JX; Zhang J; Yan W; Wang YY; Han L; Yue X; Liu N; You YP; Jiang T; Pu PY; Kang CS
Neuro Oncol; 2013 Mar; 15(3):279-89. PubMed ID: 23295773
[TBL] [Abstract][Full Text] [Related]
9. Integrative subtype discovery in glioblastoma using iCluster.
Shen R; Mo Q; Schultz N; Seshan VE; Olshen AB; Huse J; Ladanyi M; Sander C
PLoS One; 2012; 7(4):e35236. PubMed ID: 22539962
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma.
Yang D; Rao G; Martinez J; Veeraraghavan A; Rao A
Med Phys; 2015 Nov; 42(11):6725-35. PubMed ID: 26520762
[TBL] [Abstract][Full Text] [Related]
11. Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner.
Duarte CW; Willey CD; Zhi D; Cui X; Harris JJ; Vaughan LK; Mehta T; McCubrey RO; Khodarev NN; Weichselbaum RR; Gillespie GY
PLoS One; 2012; 7(1):e29653. PubMed ID: 22242177
[TBL] [Abstract][Full Text] [Related]
12. Deep learning identified glioblastoma subtypes based on internal genomic expression ranks.
Mao XG; Xue XY; Wang L; Lin W; Zhang X
BMC Cancer; 2022 Jan; 22(1):86. PubMed ID: 35057766
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
[TBL] [Abstract][Full Text] [Related]
14. Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
Lu J; Cowperthwaite MC; Burnett MG; Shpak M
PLoS One; 2016; 11(4):e0154313. PubMed ID: 27124395
[TBL] [Abstract][Full Text] [Related]
15. Differential H
Zaher A; Mapuskar KA; Sarkaria JN; Spitz DR; Petronek MS; Allen BG
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138986
[TBL] [Abstract][Full Text] [Related]
16. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma.
Park J; Shim JK; Yoon SJ; Kim SH; Chang JH; Kang SG
Sci Rep; 2019 Jul; 9(1):10555. PubMed ID: 31332251
[TBL] [Abstract][Full Text] [Related]
18. Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes.
Pal S; Bi Y; Macyszyn L; Showe LC; O'Rourke DM; Davuluri RV
Nucleic Acids Res; 2014 Apr; 42(8):e64. PubMed ID: 24503249
[TBL] [Abstract][Full Text] [Related]
19. Perspective of mesenchymal transformation in glioblastoma.
Kim Y; Varn FS; Park SH; Yoon BW; Park HR; Lee C; Verhaak RGW; Paek SH
Acta Neuropathol Commun; 2021 Mar; 9(1):50. PubMed ID: 33762019
[TBL] [Abstract][Full Text] [Related]
20. Drug repurposing for glioblastoma based on molecular subtypes.
Chen Y; Xu R
J Biomed Inform; 2016 Dec; 64():131-138. PubMed ID: 27697594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
